Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Senti Biosciences (SNTI) Receivables - Net (2021 - 2025)

Senti Biosciences has reported Receivables - Net over the past 5 years, most recently at $323000.0 for Q4 2025.

  • Quarterly results put Receivables - Net at $323000.0 for Q4 2025, down 53.86% from a year ago — trailing twelve months through Dec 2025 was $323000.0 (down 53.86% YoY), and the annual figure for FY2025 was $323000.0, down 53.86%.
  • Receivables - Net for Q4 2025 was $323000.0 at Senti Biosciences, down from $600000.0 in the prior quarter.
  • Over the last five years, Receivables - Net for SNTI hit a ceiling of $18.6 million in Q2 2024 and a floor of $323000.0 in Q4 2025.
  • Median Receivables - Net over the past 5 years was $846000.0 (2022), compared with a mean of $4.5 million.
  • Peak annual rise in Receivables - Net hit 3184.66% in 2024, while the deepest fall reached 96.02% in 2024.
  • Senti Biosciences' Receivables - Net stood at $483000.0 in 2021, then skyrocketed by 75.16% to $846000.0 in 2022, then skyrocketed by 1979.43% to $17.6 million in 2023, then crashed by 96.02% to $700000.0 in 2024, then crashed by 53.86% to $323000.0 in 2025.
  • The last three reported values for Receivables - Net were $323000.0 (Q4 2025), $600000.0 (Q3 2025), and $3.5 million (Q2 2025) per Business Quant data.